

























![]()
Eurofins Scientific SE (ERFSF) Q1 2026 Sales/Trading Call April 22, 2026 9:00 AM EDT
Company Participants
Gilles Martin - Chairman of the Board & CEO
Conference Call Participants
Remi Grenu - Morgan Stanley, Research Division
Neil Tyler - Rothschild & Co Redburn, Research Division
Delphine Le Louet - Bernstein Institutional Services LLC, Research Division
Suhasini Varanasi - Goldman Sachs Group, Inc., Research Division
Presentation
Operator
Good day, ladies and gentlemen. Welcome, and thank you for joining Eurofins' First Quarter 2026 Trading Update Conference Call. Please note that this call is being recorded and will later be available for replay on Eurofins' Investor Relations website. [Operator Instructions] During this call, Eurofins' management may make forward-looking statements, including, but not limited to, statements with respect to outlook and the related assumptions.
Management will also discuss alternative performance measures such as organic growth and EBITDA, which are defined in the footnotes of our press release. Actual results may differ materially from objectives discussed. Risks and uncertainties that may affect Eurofins' future results include, but are not limited to, those described in the Risk Factors section of the most recent Eurofins annual and half year reports. Please also read the disclaimer on Page 2 of this presentation, subject to which this call and the Q&A session are made. I would now like to turn the conference over to Dr. Gilles Martin, Eurofins' Chief Executive Officer. Please go ahead.
Gilles Martin
Chairman of the Board & CEO
Hello, everybody, and welcome to our quarterly call. So in the first quarter, we only -- in the third quarter, we only published -- it's a limited comment that I will make today. In Q1 was a continuation of last year. We've had a softer revenue growth with a big impact on weather. Those who live in North America, in the Midwest or the East Coast and even in the South will
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。